drugset / Trial / NCT02369068
Onabotulinumtoxin A Versus Kenalog for Chronic Pelvic Pain
RandomizedParallel-groupDouble-blindTreatment
Summary
The goal of this study is to compare the effectiveness of two different medications used in intravaginal trigger point injections (injections into extremely painful areas of a muscle) to treat chronic pelvic pain. The study compares onabotulinumtoxinA (BOTOX®) (a drug prepared from the bacterial toxin botulin which temporarily paralyzes muscles) to Kenalog (a synthetic corticosteroid used as an anti-inflammatory agent).
Timeline
- Start
- 2015-08
- Primary completion
- 2018-03-26
- Completion
- 2018-09-24
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Botulinum toxin type A | Protein / enzyme biologic | 200 iu | Other |
| Comparator | Triamcinolone Acetonide | Other / unclassified | 40 mg | Other |